Physician profile
Heather L Neville
NPI 1194946855
$9,824.65
in general payments reported to CMS, 2019-2025
41 companies · $3,574 in 2025
The $3,574 reported for 2025 was more than what 97% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $542 · 2020: $466 · 2021: $982 · 2022: $596 · 2023: $1,251 · 2024: $2,414 · 2025: $3,574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,800 · Food and Beverage: $2,339 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,800.00 |
| Food and Beverage | $2,338.90 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $4,800.00 | 2024-2025 | Bovine Collagen |
| Abbvie INC. | $1,043.05 | 2019-2025 | |
| Astellas Pharma US INC | $446.70 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $401.97 | 2021-2025 | |
| Exeltis, USA INC. | $342.72 | 2019-2025 | Slynd, Tyblume |
| Biogen, INC. | $246.30 | 2024-2025 | Zurzuvae, Vumerity |
| Therapeuticsmd, INC. | $193.39 | 2019-2022 | |
| Organon LLC | $174.23 | 2021-2025 | Nexplanon, Nuvaring |
| Sumitomo Pharma America, INC. | $155.81 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $150.98 | 2021-2025 | Aptima, Myosure Tissue Removal Device, Novasure |
| Evofem Biosciences, INC. | $148.12 | 2021-2022 | |
| Avion Pharmaceuticals | $143.75 | 2019-2023 | Balcoltra |
| Millicent US INC | $141.02 | 2019-2025 | Femlyv |
| Covidien Lp | $134.34 | 2019 | |
| Agile Therapeutics, INC. | $125.40 | 2021-2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $120.11 | 2022-2025 | |
| Daiichi Sankyo INC. | $111.89 | 2022-2023 | Injectafer |
| Shield Therapeutics INC | $108.92 | 2023-2024 | Accrufer |
| Novo Nordisk INC | $107.49 | 2023 | Wegovy |
| Aspira Women'S Health INC | $64.04 | 2022 | |
| Amag Pharmaceuticals, INC. | $55.57 | 2019-2020 | |
| Coopersurgical, INC. | $54.90 | 2021-2024 | Fisherbrand Disposable Liquid Infant Heel Warmer |
| Myriad Women'S Health, INC. | $51.76 | 2023 | Myrisk |
| Vertical Pharmaceuticals, LLC | $49.23 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $46.94 | 2020-2021 | |
| Allergan, INC. | $44.66 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $35.40 | 2020-2024 | Gardasil, Gardasil 9 |
| Lupin INC. | $34.69 | 2021 | |
| Meditrina | $34.19 | 2023-2025 | |
| Pfizer INC. | $32.52 | 2019-2025 | |
| Minerva Surgical, INC | $31.20 | 2019-2024 | |
| Nevro Corp. | $29.49 | 2019 | |
| Axonics, INC. | $24.59 | 2023 | Bulkamid |
| Molnlycke Health Care US, LLC | $20.93 | 2025 | Mepilex Border Post-Op Ag, Avance |
| Novum Pharma, LLC | $20.93 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.42 | 2021 | |
| Duchesnay USA Incorporated | $18.32 | 2019 | |
| Myovant Sciences INC. | $18.21 | 2021 | |
| Exact Sciences Corporation | $14.81 | 2025 | |
| Mission Pharmacal Company | $14.00 | 2020 | |
| Ibsa Pharma INC. | $12.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Neville listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.